abstract |
The present invention relates to a pharmaceutical composition for treating or preventing macular degeneration, and more particularly, to a recombinant vector containing soluble VEGF receptor variant cDNA and a pharmaceutical composition for treating or preventing macular degeneration comprising the same, , It is possible to effectively treat age-related macular degeneration, which is a typical retinal disease that causes adult blindness, and to expect a preventive effect. |